Position history for BAKER BROS. ADVISORS LP's holdings in BIOCRYST PHARMACEUTICALS INC
BAKER BROS. ADVISORS LP holds 2.8M shares of BCRX (BIOCRYST PHARMACEUTICALS INC), worth $22M as of 2025-Q4. This is a new position. BCRX represents 0.1% of BAKER BROS. ADVISORS LP's portfolio.
Current Value
$22M
Current Shares
2.8M
Total Value Change
+$21.5M
Total Shares Change
+2.7M
Other major holders of BCRX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, BNP PARIBAS FINANCIAL MARKETS
New |
| 2.8M |
- |
| $22M |
| 0.1% |
| $7.66 |
47 |
| 2024-Q4 | Exited | 0 | -100.0% | $0 | 0.0% | $7.53 | 0 |
| 2024-Q3 | Unchanged | 75,778 | 0.0% | $575,913 | 0.0% | $7.62 | 0 |
| 2024-Q2 | Decreased | 75,778 | -99.3% | $468,308 | 0.0% | $6.18 | 0 |